Assessing social vulnerabilities of salivary gland cancer care, prognosis, and treatment in the United States.
Head Neck
; 46(9): 2152-2166, 2024 09.
Article
em En
| MEDLINE
| ID: mdl-38651501
ABSTRACT
BACKGROUND:
Salivary gland cancers (SGC)-social determinants of health (SDoH) investigations are limited by narrow scopes of SGC-types and SDoH. This Social Vulnerability Index (SVI)-study hypothesized that socioeconomic status (SES) most contributed to SDoH-associated SGC-disparities.METHODS:
Retrospective cohort of 24 775 SGCs assessed SES, minority-language status (ML), household composition (HH), housing-transportation (HT), and composite-SDoH measured by the SVI via regressions with surveillance and survival length, late-staging presentation, and treatment (surgery, radio-, chemotherapy) receipt.RESULTS:
Increasing social vulnerability showed decreases in surveillance/survival; increased odds of advanced-presenting-stage (OR 1.12, 95% CI 1.07, 1.17), chemotherapy receipt (OR 1.13, 95% CI 1.03, 1.23); decreased odds of primary surgery (0.89, 0.84, 0.94), radiotherapy (0.91, 0.85, 0.97, p = 0.003) for SGCs. Trends were differentially correlated with SES, ML, HH, and HT-vulnerabilities.CONCLUSIONS:
Through quantifying SDoH-derived SGC-disparities, the SVI can guide targeted initiatives against SDoH that elicit the most detrimental associations for specific sociodemographics.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias das Glândulas Salivares
País/Região como assunto:
America do norte
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Estados Unidos